With clear FDA path, Clementia raises $70.2M

With clear FDA path, Clementia raises $70.2M

Submitted by admin on October 31, 2018 - 9:52am
Source: 
BioCentury
News Tags: 
Clementia Pharmaceuticals
fibrodysplasia ossificans progressiva
palovarotene
Headline: 
With clear FDA path, Clementia raises $70.2M
snippet: 

Days after revealing regulatory plans for its therapy for a rare bone disease, Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) raised $70.2 million in a bumped-up follow-on offering.

Do Not Allow Advertisers to Use My Personal information